Clinical Trial Update: Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial in multiple myeloma compared thalidomide with dexamethasone against melphalan/prednisone for induction, and thalidomide with interferon …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Alkeran (melphalan)
• DEXAMETHASONE (Dexamethasone)
• Deltasone (prednisone)
• Intron A (interferon alfa-2b)
• Thalomid (thalidomide)

Snippet

Sponsor: Austrian Forum Against Cancer | Conditions: Multiple Myeloma | Phase 2, Phase 3 | Status: COMPLETED